Cardiovascular-kidney-metabolic syndrome recommendations replace those issued in 2013 on obesity and are intended for cardiologists, endocrinologists, nephrologists and primary care clinicians.
A Health Canada safety review assesses the potential risk of weight loss in children under age six who are prescribed off-label central nervous system stimulants for ADHD.